Metastatic mixed acinar-neuroendocrine carcinoma of the pancreas treated by a multidisciplinary team: A case report and brief review of the literature Dear editors, Ranked one of the most common cancers globally, pancreatic cancer is recognized as "the king of cancer" because of its highly malignant behavior. 1 Pancreatic cancer develops from either the endocrine (islet cell) or exocrine (ductal or acinar cell) system of the pancreas, and can mainly be categorized into three types: ductal, acinar, or endocrine.Although ductal adenocarcinoma is the most common type of pancreatic cancer, neuroendocrine carcinoma is a rarity in histopathology which accounts for approximately 1%-2% of all pancreatic neoplasms. 2 Another rare entity is the acinar carcinoma that constitutes only 1% of all pancreatic cancers. 3 More importantly, the mixed acinarneuroendocrine carcinoma (MANEC), which is the rarest pancreatic neoplasm with an incidence of 0.2% as reported in a large-scale study, 4 exhibits the morphological characteristics of both acinar cell and neuroendocrine carcinomas. Here we presented a case of MANEC with liver metastasis confirmed by liver biopsy, and discussed the features of the tumor and its therapeutic insights by literature review.